Susanne Haas

Summary

Affiliation: University of Bonn
Country: Germany

Publications

  1. ncbi Autoimmune enteric leiomyositis: a rare cause of chronic intestinal pseudo-obstruction with specific morphological features
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Germany
    Hum Pathol 36:576-80. 2005
  2. ncbi Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use
    S Haas
    Department of Otolaryngology, Head and Neck Surgery, University Hospital of Mannheim, Germany
    Oral Oncol 38:618-23. 2002
  3. ncbi [Langerhans' cell histiocytosis of the liver. Differential diagnosis of a rare chronic destructive sclerosing cholangitis]
    S Haas
    Institut fur Pathologie, Rheinische Friedrich Wilhelms Universitat Bonn
    Pathologe 24:119-23. 2003
  4. ncbi Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, D 53127 Bonn, Germany
    Oncol Rep 21:299-304. 2009
  5. ncbi Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Susanne Haas
    Institute of Pathology, Sigmund Freud Str 25, D 53127, Bonn, Germany
    Virchows Arch 452:277-83. 2008
  6. ncbi Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Sigmund Freud Street 25, D 53127 Bonn, Germany
    Int J Cancer 119:1785-91. 2006
  7. ncbi Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, FRG
    Am J Surg Pathol 31:902-6. 2007
  8. ncbi Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Sigmund Freud Str 25, D 53127 Bonn, Germany
    Pathol Res Pract 205:716-25. 2009
  9. ncbi Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands
    Annette Pantelis
    Department of Otorhinolaryngology Surgery, University of Bonn, D 53105 Bonn, Germany
    Oral Oncol 45:526-30. 2009
  10. ncbi Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, D-53127 Bonn, Germany
    Int J Mol Med 16:815-9. 2005

Detail Information

Publications14

  1. ncbi Autoimmune enteric leiomyositis: a rare cause of chronic intestinal pseudo-obstruction with specific morphological features
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Germany
    Hum Pathol 36:576-80. 2005
    ..Therefore, correct diagnosis may be missed in peroral and peranal mucosal biopsies, but full-thickness biopsies are required...
  2. ncbi Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use
    S Haas
    Department of Otolaryngology, Head and Neck Surgery, University Hospital of Mannheim, Germany
    Oral Oncol 38:618-23. 2002
    ..Our results implicate that there are factors other than tobacco consumption which may influence the development of head and neck cancers at distinct tumor sites...
  3. ncbi [Langerhans' cell histiocytosis of the liver. Differential diagnosis of a rare chronic destructive sclerosing cholangitis]
    S Haas
    Institut fur Pathologie, Rheinische Friedrich Wilhelms Universitat Bonn
    Pathologe 24:119-23. 2003
    ..Therefore, LCH is an important differential diagnosis of chronic destructive cholangitis with cholestatic liver disease, especially in children and young adults. The diagnosis can be verified by S-100 and CD1a immunohistochemistry...
  4. ncbi Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, D 53127 Bonn, Germany
    Oncol Rep 21:299-304. 2009
    ..Our results cannot support the hypothesis of a transactivation of HER-2 and thus a possible therapeutic benefit of trastuzumab in HER-2 negative breast cancers...
  5. ncbi Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Susanne Haas
    Institute of Pathology, Sigmund Freud Str 25, D 53127, Bonn, Germany
    Virchows Arch 452:277-83. 2008
    ..Tissue specimen for ELISA analysis should not be taken from the tumor area around the biopsy channel in the resection specimen...
  6. ncbi Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Sigmund Freud Street 25, D 53127 Bonn, Germany
    Int J Cancer 119:1785-91. 2006
    ..They particularly suggest that GST mu and pi expression may indicate a better prognosis and that strong CYP3A4/5 and CYP1B1 expression may be key features of nonfavourable prognosis...
  7. ncbi Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, FRG
    Am J Surg Pathol 31:902-6. 2007
    ..As CD56 expression is also found in reactive bile ducts and bile duct adenomas, one may speculate that these rare neoplasms may originate from reactive bile ducts or cholangiomatous lesions...
  8. ncbi Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, Sigmund Freud Str 25, D 53127 Bonn, Germany
    Pathol Res Pract 205:716-25. 2009
    ..Therefore, reduced expression of GST alpha and CYP3A4 may indicate specific metabolic defects in the tumor tissue characterizing subgroups of HCA and HCC...
  9. ncbi Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands
    Annette Pantelis
    Department of Otorhinolaryngology Surgery, University of Bonn, D 53105 Bonn, Germany
    Oral Oncol 45:526-30. 2009
    ..These data support the hypothesis that hBD-1 might be a potential tumor suppressor also in benign salivary gland tumors in addition to other genetic alterations...
  10. ncbi Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women
    Susanne Haas
    Institute of Pathology, Medical Faculty of the University of Bonn, D-53127 Bonn, Germany
    Int J Mol Med 16:815-9. 2005
    ..Our results indicate the inclusion of otherwise rare HPV types in screening programs for HIV positive and immunosuppressed patients...
  11. ncbi A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    Matjaz Rokavec
    Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
    Clin Cancer Res 13:7506-14. 2007
    ..To understand the role of genetic variations in the regulation of ERBB4 expression, we identified new polymorphisms and investigated their functional implication and risk association with breast and colorectal cancer...
  12. ncbi Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
    Montserrat Garcia-Closas
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Marylan, United States of America
    PLoS Genet 4:e1000054. 2008
    ..Understanding the etiologic heterogeneity of breast cancer may ultimately result in improvements in prevention, early detection, and treatment...
  13. ncbi Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer
    Benny K Abraham
    Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, D 70376 Stuttgart, Germany
    Cancer Epidemiol Biomarkers Prev 14:1102-7. 2005
    ..032). Our data suggest that variants of the hemochromatosis-transferrin receptor system have no direct effect on the incidence of breast cancer in Germany. Possible effects on tumor progression and prognosis remain elusive...
  14. ncbi The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer
    Christina Justenhoven
    Molecular Mechanisms of Origin and Treatment of Breast Cancer, Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, 70376, Stuttgart, Germany
    Breast Cancer Res Treat 111:171-7. 2008
    ..We conclude that the CYP1B1_1358_A>G polymorphism has an impact on ERalpha status in breast cancer in that the CYP1B1_1358_GG genotype known to encode higher CYP1B1 activity is associated with ERalpha negativity...